lymphadenopathy and granulomatous tubuloinsterstitial nephritis with nephrogenic diabetes insipidus. In the setting of sarcoidosis, cranial DI is more common than nephrogenic DI, but both should be considered in sarcoid patients presenting with polyuria and polydipsia. Granulomatous interstitial nephritis is not uncommon in sarcoid however other conditions which mimic GIN must be excluded, which include allergic reactions, chronic fungal or mycobacterial infections and neoplasia. Serum ACE levels are increased in many patients with chronic kidney disease or endstage renal disease of varying causes. The degree of elevation does not correlate with severity of the underlying renal failure. The majority of renal sarcoid is due to hypercalcaemia and hypercalciuria, and the true incidence of renal involvement in sarcoid is unknown as is the progression to CKD. Rheumatologists need to consider the renal manifestations of sarcoidosis when assessing these patients, particularly those with hypercalcemia, and should screen with 24 hour urinary calcium collections, renal ultrasound and considerreferral tonephrologists.
Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UNITED KINGDOM Introduction: Haemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory syndrome, characterised by the inappropriate survival of histiocytes and cytotoxic T-lymphocytes. HLH is underrecognised but should be suspected in the deteriorating, febrile patient and may present to any medical speciality. Delay in treatment leads rapidly to critical illness and death. Primary HLH results from a genetic defect which usually presents in infancy and is treated by stem cell transplant. Secondary HLH is classically triggered by autoimmune disease, particularly systemic juvenile idiopathic arthritis (sJIA) or systemic lupus eythematosis (SLE) when it is termed macrophage activation syndrome (MAS). It isalso triggered by infection (particularly Epstein Barr virus and Varicella Zoster) and malignancy (especially lymphoma). In adults mortality of HLH is 50-75% almost certainly because of late recognition and treatment. Diagnosis requires a high index of suspicion and interpretation of common investigations including full blood count (FBC), lipids, fibrinogen, liver function tests (LFT) and serum ferritin (often highly elevated >10,000 lg/L pathognomic of HLH/MAS in absence of iron overload). Bone marrow biopsy is not required for diagnosis. The H-score can be used to calculate the probability of secondary HLH and in the context of sJIA there are agreed diagnostic MAS criteria. Treatment of HLH involves aggressive immunosuppression, alongside management of the underlying trigger and recent guidance for recognition and treatment of adults with acquired HLH has been published. Due to lack of awareness of HLH among physicians diagnosis may be delayed or even missed leading to poor outcomes, highlighting a potential to improve identification and treatment of HLH and save lives as a result. Rheumatologists have a key part to play in recognition and treatment of HLH/MAS. We present four cases of HLH seen between 2014-2017 highlighting the clinical features, diagnosis and management strategies to promote the rheumatologygeneral medicine interface. Case description: Case 1: An HLH post-stem cell transplant 55-year-old man, usually fit and well, diagnosed with chronic myeloid leukaemia (CML) underwent allogenic stem cell transplant. Three months later presented with transaminitis, rash and diarrhoea and treated for graftversus-host disease (GvHD). Three months later, he was admitted with acute confusion, acute kidney injury (AKI) and pancytopenia, requiring intensive therapy unit (ITU) admission. He was treated presumptively for infection although no positive cultures were obtained. Eight months later he presented with fever and rigors and splenomegaly: a bone marrow biopsy showed reactive changes. There were no positive cultures from blood, CSF, urine, throat, skin or Hickmann line. Ferritin was 33 376lg/L, triglycerides 3.7mmol/L, fibrinogen 1.1g/L raising the suspicion of HLH. He was started on dexamethosone and ciclosporin A (CSA) which showed clinical improvement but intermittent pyrexia. He deteriorated twelve days later with type 1 respiratory failure and hypotension, requiring further ITU admission at which point his ferritin was > 100 000lg/L. He was then treated with intravenous (IV) methylprednisolone (MP) and IV Immunoglobulin (IVIg) and also rituximab, as EBV PCR was 54 700 copies/mL, the likely trigger for HLH. Ferritin started to fall but he had worsening AKI and persistent cytopenia so he was given Anakinra, in an attempt to terminate the cytokine storm. There was a swift improvement, and he was restarted on oral prednisolone and anakinra was withdrawn. He deteriorated again with confusion and pyrexia, requiring readmission to ITU. After initially repeating IVMP and IVIG, anakinra was reintroduced with good effect. He was eventually discharged on anakinra and despite CKD and persistently abnormal LFTs,he has remained well. Case 2: An HLH post varicella zoster infection 74-year-old man with bronchiectasis, but a high functional level, admitted with 10 days of fatigue, lethargy and intermittent confusion. Despite three days of treatment for pneumonia with IV tazocin he became more confused, developed abnormal liver function tests (LFTs) and remained febrile. Despite no positive cultures he was escalated to meropenem, but continued to spike temperatures and developed a pancytopenia, prompting a haematology review and bone marrow biopsy. He was resuscitated after cardiac arrest and taken to ITU. At this point, an ITU consultant queried HLH, with ferritin on 15 554lg/L despite no clear trigger. It then transpired he had shingles three weeks prior to admission and hadn't been quite right since. He was treated with IVMP and IVIG resulting in rapid resolution of pyrexia and normalisation of ferritin level and full blood count. After discharge from ITU, he made little communicative progress and a CT head demonstrated significant hypoxic brain injury from the cardiac arrest, making chance of recovery slim. He died aweek later following asecond cardiac arrest. Case 3: An HLH in sJIA 17-year-old man with sJIA and previous pericarditis, treated with methotrexate (MTX) and tocilizumab (TOC) was admitted with two days of fever and productive cough. He was treated for pneumonia but rapidly deteriorated prompting ITU admission and intubation. He had persistent pyrexia, worsening rash (attributed to his sJIA) and deteriorating LFTs. He had a generalised seizure and was admitted to a specialist neuro ITU. His ferritin was 24 814lg/L, with neutropenia, thombocytopenia and a bone marrow biopsy showing evidence of haemophagocytosis. An MRI brain demonstrated vasogenic oedema, consistent with posterior reversible encephalopathy syndrome (PRES), the aetiology of which presumed to be a combination of HLH and ciclosporin toxicity. He remained neutropenic but well, until deterioration with worsening generalised maculopapular rash. He was treated with IVMP, CSA (until he developed toxicity) and IVIG. Despite this he remained unwell and required etoposide, a powerful chemotherapeutic agent with antimacrophage effects. He made a complete recovery within a week and stabilised onTOC and MTX. Case 4: An HLH in SLE 39-year-old Chinese man, living in the UK for 10 years, with no past medical history admitted following a collapse. He also reported recent history of oral ulcers, joint pain, rash, night sweats, weight loss (10kg) and it was noted that he was confused, abbreviated mental test (AMT) 7/10. On examination he was febrile, and had cervical/axillary/ iliac lymphadenopathy. Urine dip showed blood and protein, with a urine protein creatinine ratio of 125. Further investigations showed a positive ANA, ENA, RNP, DsDNA and low complement, consistent with systemic lupus erythematosus (SLE). Six days post-admission, he had a rapid deterioration in consciousness with Glasgow coma scale (GCS) of six. Blood tests showed worsening liver function, ferritin 52 000lg/L and raised triglycerides. He was treated for HLH with IVMP and IVIG, resulting in rapid resolution of pyrexia, return to GCS of 15 and progressive improvement in rash, joint pain and proteinuria. He remained stable on a reducing wean of oral prednisolone along with introduction of mycofenylate mofetil (MMF) and hydroxychlorquine (HCQ). Discussion: Secondary HLH is under-recognised in adolescent and adult patients and should be considered in both the rheumatology and general medical population. New guidance suggests that early treatment with immunosuppression (initially methylprednisolone þ/-IVIG and early consideration of anakinra) is both safe and effective in the critically unwell patient so raising awareness of HLH is key. Clinicians need to have a high index of suspicion and in particular should think of HLH in patients with fever, confusion, hepatosplenomegaly, dual or pan-lineage cytopenia and multi-organ failure. Serum markers ferritin, triglycerides, fibrinogen and LFTs can be used alongside the clinical features to guide diagnosis. The H-score, a free online calculator, is a validated tool, into which these parameters are inputted to give a probability of HLH. The two rheumatology cases here demonstrate that rheumatologists are aware of HLH and treat early with good outcome. We have presented two general medical cases also with relatively good outcome reflecting the HLH network set up in our Trust resulting in both patients having early recognition of HLH by their non-rheumatology parent teams and early, combined intervention. We recognize that HLH generally and particularly that presenting as a result of lymphoma or other malignancy has a poor outcome. Our HLH network would suggest that HLH is not rare; between 2014 and 2018 we have been involved in managing around 30 cases. Better awareness of HLH in rheumatology and beyondwill improve patient care Key Learning Points: The febrile, thrombocytopaenic and unwell/deteriorating with no identified pathogen or disease should mandate estimation of serum ferritin and consideration of HLH. Screen these patients using serum ferritin, and stratify their risk of HLH using the H score Early treatment involving IVMP, IVIG, CSA and Anakinra can help to abort the cytokine storm, but the underlying trigger, such as EBV infection, malignancy or autoimmune disease must be treated concurrently. Introduction: Discogenic hemi-vertebral sclerosis is a rare condition of localised sclerotic or lytic lesions affecting vertebral bodies in adults. It is of unknown aetiology and regarded as a do not touch lesion. We report the first case where this lesion has been confused fora fracture. Case description: A 48 year old female patient presented with a 20 year history of mechanical back pain, neck, left shoulder, knee and ankle pain. ShehadahistoryofaL5/S1discbulgeresultinginnerverootcompression which was successfully treated with an L5/S1 nerve root block injection under the spinal surgeons three years previously. The patient had a lumbo-sacral radiograph performed due to a back injury 20 years ago which reported multiple Schmorl's nodes, disc space narrowing at L5/S1 and facetal spondylosis from L4 to S1; namely degenerative changes only. Ongoing back pain led to a repeat lumbar spine radiograph which identified degenerative and modic end plate changes in 2014 and a computed tomography scan of the abdomen and pelvis with contrast 3/11/ 2014 reported as degenerative changes at L5/S1 does in fact show endplate sclerosis at L5/S1. The patient was never seen by a rheumatologist and no other further testing performed however her father also had a diagnosis of ankylosing spondylitis. Past medical history includes renal calculi, frozen shoulder, double uterus and caesarean section. On examination she was able to mobilise unaided, lumbar spine movements were slightly restricted however Schober's test was just within normal limits at 5cm. Cervical spine mobility was restricted in extension and rotation at half range movement with crepitus. Left shoulder joint mobility was reduced to flexion 110, abduction 90 and internal rotation 3 =4 and external rotation half range with a full range of passive movement at the left shoulder. ESR and CRP were not significantly raised at 19 mm/hr (1-12) and 10 mg/l (0-5) respectively, bone profile, Vitamin D studies and immunoglobulins were normal. HLA B27 was negative. MRI of whole spine identified loss of normal cervical lordosis with posterior disc osteophyte complex at C5-C6, C6-C7 and C7-T1 causing thecal sac compression only and minor insignificant disc protrusions were seen at the T-spine. The report stated that in the lumbar spine there is a linear horizontal low signal across the L5 and S1 vertebral body in keeping with a fracture. Short TI inversion recovery identified minor oedema at the site. Other changes include degenerative change and loss of disc height at L5-S1, diffuse disc bulge at L4-5 and mild oedema at left sacroiliac joint inferiorly. These appearances suggest degenerative change. Although the magnetic resonance imaging scan of the spine report suggested the presence of L5 and S1 vertebral body fractures; this seemed unlikely in the absence of any history of trauma and her normal bone mineral density. The dual energy x-ray absorptiometry scan reported a T score of þ 1.0 at the femoral neck and þ0.6 at the lumbar spine. Therefore further review of the imaging at the rheumatology/radiology meeting with the musculoskeletal radiologist identified discogenic hemi-vertebral sclerosis at the level of L5 and S1simulating fractures therebyresolving the issue. Discussion: Discogenic hemi-vertebral sclerosis is a rare usually sclerotic, but occasionally lytic or mixed lytic-sclerotic lesion which typically arises in the clinical context of a middle aged woman with chronic low back pain. Ithas previously been reported that thislesion canbeconfused with the appearance of a bony metastases or infection but never as a fracture. It is always situated adjacent to the vertebral end plate and usually associated with degenerative changes such as narrowed disc space, Schmorl's nodes and osteophytes all of which were identified on the patient's imaging. Discogenic sclerosis can also mimic infectious spondylitis which also presents with narrowed disc space, sclerosis of adjacent vertebral bodies and abnormalities of the vertebral end plate therefore correct identification is vital to prevent unnecessary biopsies and further investigation as the management is conservative. However, diagnosis is challenging and requires correlation of the clinical features with radiological findings which include: rounded sclerosis most frequently in the anterior vertebral body (100%); central lucency in the sclerosis (77%); associated degenerative changes at the intervertebral disc, e.g. vacuum phenomena (44%); absence of a para-spinal mass and maintenance of vertebral body height. This patient underwent several imaging modalities before the correct diagnosis was made. Fortunately, she did not undergo any unnecessary invasive procedures, to repair the supposed vertebral fractures or for further diagnostic value, highlighting the importance of recognising this unusual presentation of discogenic hemi-vertebral sclerosis. Key Learning Points: Discogenic hemi-vertebral sclerosis appears at the end plate and is usually associated with a narrowed disc space and degenerative changes. Discogenic sclerosis can mimic infection, fracture or bony metastases. Correct diagnosis is important to prevent unnecessary biopsy. Disclosure: Z.M. Sardar: None. Introduction: Rat bite fever (RBF) is a zoonosis and rare presentation to hospital. Its known causative organisms are Streptobacillus moniliformis and Spirillum minus, the latter of which is almost exclusively restricted to Asia. These organisms are the normal oral and nasopharyngeal flora found within rodents. The most common route of transmission is via bites or scratches, but it has also been noted that it may infrequently be transferred simply by handling rodents. There are approximately 1-2 cases per year reported within the UK. Due to its rarity and remitting non-specific symptoms of pyrexia, headache, myalgia, migratory polyarthralgia and maculopapular rash, it often poses a diagnostic conundrum. It has been noted that the condition can be self-limiting but can also have serious complications such as endocarditis and meningitis. Rapid treatment is therefore of paramount importance, as it has been reported that mortality may reach as high as 7-13% without adequate intervention with antibiotics, such as penicillins, in severe cases. More frequently, this infection may last several months without improvement and may inappropriately be treated as an autoimmune condition. Immunosuppression could worsenprognosis. Case description: A 67 year old white British man presented to the acute medical unit with a one-week history of malaise and difficulty mobilising. He was an ex-smoker and had a background of hypertension and ischaemic heart disease. He had experienced vomiting and diarrhoea, with no blood or mucus in the stool. He had developed bilateral ankle pain over the past few days with swelling, and a bilateral pinpoint purpuric maculopapular rash over the lower limbs developing the day prior to admission. He was not on any regular medication and had no known drug allergies. On admission he had a temperature of 39 o C but remained haemodynamically stable. It was noted on examination that he had an ejection systolic murmur louder on expiration, but no other abnormalities were found on cardiovascular or respiratory assessment. His abdomen was soft and there was no organomegaly. His right third metacarpophalangeal joint was noted to be swollen and erythematous, as was the left sternoclavicular joint. Both ankles were oedematous and painful. Initial blood samples showed a raised CRP of 271, white cell count (WCC) 15.1, with no other abnormalities. ECG showed sinus rhythm, but the urine alysis was mildly positive for protein and showed trace blood. Due to the development of a previously unknown murmur and pyrexia, he was initially treated for possible infective endocarditis. The rash and urinalysis also led to a differential of autoimmune vasculitis. Initial investigations included three sets of blood cultures and a transthoracic echocardiogram. He was started on intravenous fluid, analgesia and was treated empirically for infective endocarditis according to trust antimicrobial guidelines (vancomycin and gentamicin). A referral was made by the acute physicians to rheumatology at this point.The initial report of the transthoracic ECHO suggested that there may be a small vegetation on the aortic valve with mild mitral regurgitation. Cardiology was consulted and a transoesophageal ECHO was organised, which ultimately showed that there was no vegetation. The initial results of the first blood culture were suggestive of a gram negative rod, so meropenem was started to cover for this organism. Microbiology reviewed the patient and suggested the additional testing of hepatitis A, B, C and HIV, all of which were negative. Rheumatologists reviewed him after this and suggested that an infective cause for the vasculitis was more likely than an autoimmune cause considering the clinical picture and recent blood culture results. Additional tests to include ANCA, ENA, double stranded DNA antibody, anti-CCP antibody and urine protein:creatinine ratio were requested to add to the overall workup, and immunosuppression was not commenced. An ultrasound scan of the left sternoclavicular joint confirmed an inflammatory arthropathy, and a CT thorax showed no obvious abnormalities. Streptobacillus moniliformis was isolated from the first blood culture. The patient then declared his hobby of keeping rats and admitted to a recent bite, thus a diagnosis of rat bite fever was made. As he had made a good clinical recovery he was converted tooral amoxicillin and discharged.
A RARE INFECTIVE CAUSE PRESENTING AS SYSTEMIC

